Zi-Chun Hua (Zichun Hua)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 4

Top Topics

Diabetic Nephropathy

Transforming Growth Factor

Metabolic Syndrome

Top Venues

EMBO molecular medicine

Cell cycle (Georgetown, Tex.)

Cancer medicine

Molecules and cells

This page only lists publications with an associated author ORCID identifier.

Publications

Huangru Xu, Ping Li, Hailin Ma, Yuanhao Tan, Xiaoyang Wang, Fangfang Cai, Jiaqi Xu, Huisong Sun, Hongqin Zhuang, Zi-Chun Hua
ADT-OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells. Cancer medicine (2023)
Yan Lin, Fangfang Cai, Xiaoyang Wang, Yunwen Yang, Yongzhe Ren, Chun Yao, Xiao-Xing Yin, Hongqin Zhuang, Zi-Chun Hua
FADD phosphorylation contributes to development of renal fibrosis by accelerating epithelial-mesenchymal transition. Cell cycle (Georgetown, Tex.) (2022)
Yan Lin, Jia Liu, Jia Chen, Chun Yao, Yunwen Yang, Jie Wang, Hongqin Zhuang, Zi-Chun Hua
FADD Phosphorylation Modulates Blood Glucose Levels by Decreasing the Expression of Insulin-Degrading Enzyme. Molecules and cells 43 (4) (2020)
Hongqin Zhuang, Xueshi Wang, Daolong Zha, Ziyi Gan, Fangfang Cai, Pan Du, Yunwen Yang, Bingya Yang, Xiangyu Zhang, Chun Yao, Yuqiang Zhou, Chizhou Jiang, Shengwen Guan, Xuerui Zhang, Jing Zhang, Wenhui Jiang, Qingang Hu, Zi-Chun Hua
FADD is a key regulator of lipid metabolism. EMBO molecular medicine 8 (8) (2016)